AusBiotech CEO Lorraine Chiroiu says the change to the R&D Tax Incentive is a "hidden detail" in the bill that will impact "vulnerable enterprises" focused on developing new therapies, devices, vaccines and diagnostics. …
Latest Video
New Stories
-
Bayer venture capital arm invests in 'off the shelf' CAR-T
July 17, 2019 - - Latest News -
Servier in new collaboration with Melbourne's BioCurate
July 17, 2019 - - Latest News -
How do we even know what patients are missing out on?
July 17, 2019 - - Latest News -
MA simply cannot say 'no' on supply chain reform
July 17, 2019 - - Latest News -
Gilead ups stake in biotech and expands cell manufacturing
July 17, 2019 - - Latest News -
Imugene acquires rights to new oncolytic virus technology
July 16, 2019 - - Latest News -
Focus on reality rather than the language
July 16, 2019 - - Latest News